Literature DB >> 28120181

Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells.

Giovanni Tulipano1, Lara Faggi2, Stefan Schulz3, Maurizio Spinello4, Andrea Giustina2,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28120181     DOI： 10.1007/s12020-017-1235-3

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  12 in total

1.  Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways.

Authors:  Renzo Cescato; Kimberly A Loesch; Beatrice Waser; Helmut R Mäcke; Jean E Rivier; Jean Claude Reubi; Agnes Schonbrunn
Journal:  Mol Endocrinol       Date:  2009-11-12

Review 2.  Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors.

Authors:  Andrea Giustina; Gherardo Mazziotti; Filippo Maffezzoni; Vito Amoroso; Alfredo Berruti
Journal:  Expert Opin Investig Drugs       Date:  2014-07-25       Impact factor: 6.206

Review 3.  Managing Cushing's disease: the state of the art.

Authors:  Annamaria Colao; Marco Boscaro; Diego Ferone; Felipe F Casanueva
Journal:  Endocrine       Date:  2014-01-11       Impact factor: 3.633

Review 4.  Somatostatin and its receptor family.

Authors:  Y C Patel
Journal:  Front Neuroendocrinol       Date:  1999-07       Impact factor: 8.606

5.  The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat.

Authors:  Giovanni Tulipano; Elena Rossi; Michael D Culler; John E Taylor; Stefania Bonadonna; Vittorio Locatelli; Daniela Cocchi; Andrea Giustina
Journal:  Regul Pept       Date:  2005-02-15

6.  Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.

Authors:  G Tulipano; L Faggi; A Cacciamali; M Spinello; D Cocchi; A Giustina
Journal:  J Neuroendocrinol       Date:  2015-01       Impact factor: 3.627

7.  Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes.

Authors:  Giovanni Tulipano; Ralf Stumm; Manuela Pfeiffer; Hans-Jürgen Kreienkamp; Volker Höllt; Stefan Schulz
Journal:  J Biol Chem       Date:  2004-03-04       Impact factor: 5.157

Review 8.  Somatostatin receptors: from signaling to clinical practice.

Authors:  Marily Theodoropoulou; Günter K Stalla
Journal:  Front Neuroendocrinol       Date:  2013-07-18       Impact factor: 8.606

9.  Expression of somatostatin receptor genes and acetylcholine receptor development in rat skeletal muscle during postnatal development.

Authors:  M Peng; L Conforti; D E Millhorn
Journal:  Int J Mol Med       Date:  1998-05       Impact factor: 4.101

10.  Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes.

Authors:  Michael Menconi; Patricia Gonnella; Victoria Petkova; Stewart Lecker; Per-Olof Hasselgren
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429
View more
  3 in total

1.  Fabula (non) acta est….Endocrine.

Authors:  Andrea Giustina
Journal:  Endocrine       Date:  2018-12       Impact factor: 3.633

2.  Does pasireotide directly modulate skeletal muscle metabolism?

Authors:  Federico Gatto; Tullio Florio
Journal:  Endocrine       Date:  2017-04-06       Impact factor: 3.633

3.  Effects of octreotide on autophagy markers and cell viability markers related to metabolic activity in rat pituitary tumor cells.

Authors:  Giovanni Tulipano; Andrea Giustina
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.